GSK-256066 (2,2,2-trifluoroacetic acid)(1415560-64-3)
- Name: GSK-256066 (2,2,2-trifluoroacetic acid)
- Synonyms:GSK256066 (2;GSK-256066; GSK 256066;2-trifluoroacetic acid);GSK256066 trifluoroacetate;GSK-256066 (2,2,2-trifluoroacetic acid);6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide 2,2,2-trifluoroacetate (1:1)
- Molecular Formula:C29H27F3N4O7S
- Molecular Weight:632.6074896
- CAS Registry Number:1415560-64-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1415560-64-3 GSK256066 (2,2,2-trifluoroacetic acid)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1415560-64-3 GSK256066 trifluoroacetate
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.1415560-64-3 GSK256066 2,2,2-trifluoroacetic acid
Assay:>98% Package:inquiry Transportation:inquiry Application:GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selectivity against PDE4B versus PDE7.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 252017-04-2/AZD7545
- 1229194-11-9/Edoxaban (tosylate monohydrate)
- 1415565-02-4/ROCK inhibitor-1
- 1033717-21-3/R-4MEMP
- 203849-91-6/MonoMethyl Dolastatin 10
- 1345614-59-6/AM-095
- 86307-44-0/1H,5H-Cyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione, 11-(3,5-dihydroxy-2-methyl-1-cyclohexen-1-yl)-4a,6,6a,7,8,9,9a,11-octa hydro-7-(5-hydroxy-1,5-dimethylhexyl)-6a-methyl-2-phenyl-, [4aR-[4aa,6aa,7a(R*),9ab,11a(3S*,5R*)]]-
- 1059734-66-5/BMS 833923
- 1265916-41-3/BIX02189
- 32222-44-9/(S)-methyl 2-(3-chlorophenyl)-2-hydroxyacetate
- 1227006-74-7/(+)-3-IPEHPC
- 1005342-46-0/LCL-161
- 931409-24-4/PF-3635659
- 1373422-53-7/GSK J1
- 949021-68-5/Sodium formononetin-3'-sulfonate
- 637774-61-9/Indolo[2,3-b]carbazole-2,10-dicarboxylic acid, 5,7-dihydro-6-methoxy-, diethyl ester
- 550999-74-1/EVP-6124 (hydrochloride)
- 1412458-61-7/Saphris hydrochloride
- 1245623-78-2/Benzeneethanol, β-amino-3-chloro-, hydrochloride (1:1), (βR)-
- 1415560-64-3/GSK-256066 (2,2,2-trifluoroacetic acid)
- 331963-29-2/I2906
- 1194374-05-4/Edivoxetine hydrochloride
- 733030-01-8/TAS-102
- 78782-98-6/Calcifediol-d6
- 1184940-46-2/(alphaS)-3,5-difluoro-alpha-hydroxybenzeneacetic acid 2-(2-ethyl-4-hydroxy-3-methylbenzoyl)hydrazide
- 1245732-48-2/G-202
- 1263369-28-3/N2'-((1r,4r)-4-aminocyclohexyl)-5'-chloro-N6-(3-fluorobenzyl)-[2,4'-bipyridine]-2',6-diamine-rel-
- 1428185-71-0/(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoromethyl)phenyl)propan-1-amine
- 882757-24-6/N,N'-[[5-[2-Amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]phosphinylidene]bis[2-methylalanine] diethyl ester
- 155294-62-5/NB 598 Maleate